Donepezil may increase the bradycardic activities of Ivabradine. Carteolol may increase the bradycardic activities of Ivabradine. The serum concentration of Ivabradine can be decreased when it is combined with Phenobarbital. Paliperidone may increase the QTc-prolonging activities of Ivabradine. The serum concentration of Ivabradine can be decreased when it is combined with Mitotane. The serum concentration of Ivabradine can be increased when it is combined with Simeprevir. Ivabradine may increase the QTc-prolonging activities of Ceritinib. Indapamide may increase the arrhythmogenic activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Primaquine. Ivabradine may increase the QTc-prolonging activities of Saquinavir. Toremifene may increase the QTc-prolonging activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Ivabradine can be increased when it is combined with Fosaprepitant. Artemether may increase the QTc-prolonging activities of Ivabradine. Quinidine may increase the QTc-prolonging activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Erythromycin. Ivabradine may increase the QTc-prolonging activities of Leuprolide. The serum concentration of Ivabradine can be increased when it is combined with Osimertinib. The serum concentration of Ivabradine can be increased when it is combined with Nefazodone. The serum concentration of Ivabradine can be increased when it is combined with Ticlopidine. Ivabradine may increase the QTc-prolonging activities of Methadone. The serum concentration of Ivabradine can be increased when it is combined with Nelfinavir. Ivabradine may increase the QTc-prolonging activities of Clozapine. The serum concentration of Ivabradine can be increased when it is combined with Rucaparib. Ivabradine may increase the QTc-prolonging activities of Granisetron. Hydroflumethiazide may increase the arrhythmogenic activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Bortezomib. The serum concentration of Ivabradine can be increased when it is combined with Boceprevir. Zuclopenthixol may increase the QTc-prolonging activities of Ivabradine. Levobunolol may increase the bradycardic activities of Ivabradine. Procainamide may increase the QTc-prolonging activities of Ivabradine. Anagrelide may increase the QTc-prolonging activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Clemastine. Ruxolitinib may increase the bradycardic activities of Ivabradine. Quinethazone may increase the arrhythmogenic activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Lenvatinib. The serum concentration of Ivabradine can be increased when it is combined with Imatinib. Vandetanib may increase the QTc-prolonging activities of Ivabradine. Carvedilol may increase the bradycardic activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Dihydroergotamine. Tizanidine may increase the bradycardic activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Gadobenic acid. Sotalol may increase the bradycardic activities of Ivabradine. The serum concentration of Ivabradine can be decreased when it is combined with Lumacaftor. The serum concentration of Ivabradine can be increased when it is combined with Doxycycline. Tetrabenazine may increase the QTc-prolonging activities of Ivabradine. Chlorothiazide may increase the arrhythmogenic activities of Ivabradine. The serum concentration of Ivabradine can be decreased when it is combined with Primidone. Ivabradine may increase the QTc-prolonging activities of Telavancin. Tofacitinib may increase the bradycardic activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Moxifloxacin. The serum concentration of Ivabradine can be increased when it is combined with Ivacaftor. Calfactant may increase the bradycardic activities of Ivabradine. Fluoxetine may increase the QTc-prolonging activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Delavirdine. Ivabradine may increase the QTc-prolonging activities of Promazine. Ivabradine may increase the QTc-prolonging activities of Crizotinib. The serum concentration of Ivabradine can be increased when it is combined with Nevirapine. Ivabradine may increase the QTc-prolonging activities of Haloperidol. Torasemide may increase the arrhythmogenic activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Levofloxacin. Guanfacine may increase the bradycardic activities of Ivabradine. Rivastigmine may increase the bradycardic activities of Ivabradine. The serum concentration of Ivabradine can be decreased when it is combined with Deferasirox. The serum concentration of Ivabradine can be decreased when it is combined with Pentobarbital. Ivabradine may increase the QTc-prolonging activities of Azithromycin. Ivabradine may increase the atrioventricular blocking (AV block) activities of Lacosamide. The serum concentration of Ivabradine can be increased when it is combined with Clotrimazole. Polythiazide may increase the arrhythmogenic activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Gemifloxacin. Disopyramide may increase the QTc-prolonging activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Mifepristone. The serum concentration of Ivabradine can be decreased when it is combined with Rifapentine. Ibutilide may increase the QTc-prolonging activities of Ivabradine. Timolol may increase the bradycardic activities of Ivabradine. The serum concentration of Ivabradine can be decreased when it is combined with Rifabutin. The serum concentration of Ivabradine can be increased when it is combined with Aprepitant. The serum concentration of Ivabradine can be increased when it is combined with Netupitant. Flupentixol may increase the QTc-prolonging activities of Ivabradine. Citalopram may increase the QTc-prolonging activities of Ivabradine. Propranolol may increase the bradycardic activities of Ivabradine. Poractant alfa may increase the bradycardic activities of Ivabradine. Eliglustat may increase the QTc-prolonging activities of Ivabradine. Dronedarone may increase the bradycardic activities of Ivabradine. Arsenic trioxide may increase the QTc-prolonging activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Atazanavir. The serum concentration of Ivabradine can be increased when it is combined with Telaprevir. The serum concentration of Ivabradine can be increased when it is combined with Posaconazole. The serum concentration of Ivabradine can be decreased when it is combined with Carbamazepine. Octreotide may increase the bradycardic activities of Ivabradine. Lucinactant may increase the bradycardic activities of Ivabradine. Thioridazine may increase the QTc-prolonging activities of Ivabradine. Chlorthalidone may increase the arrhythmogenic activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Ziprasidone. Ivabradine may increase the QTc-prolonging activities of Droperidol. Cyclopenthiazide may increase the arrhythmogenic activities of Ivabradine. Iloperidone may increase the QTc-prolonging activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Panobinostat. The serum concentration of Ivabradine can be increased when it is combined with Sildenafil. The serum concentration of Ivabradine can be increased when it is combined with Cobicistat. The serum concentration of Ivabradine can be increased when it is combined with Lopinavir. The serum concentration of Ivabradine can be decreased when it is combined with Vemurafenib. Ivabradine may increase the QTc-prolonging activities of Goserelin. The serum concentration of Ivabradine can be increased when it is combined with Luliconazole. Galantamine may increase the bradycardic activities of Ivabradine. Escitalopram may increase the QTc-prolonging activities of Ivabradine. Esmolol may increase the bradycardic activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Fusidic Acid. Dofetilide may increase the QTc-prolonging activities of Ivabradine. Methyclothiazide may increase the arrhythmogenic activities of Ivabradine. Piretanide may increase the arrhythmogenic activities of Ivabradine. Nebivolol may increase the bradycardic activities of Ivabradine. Etacrynic acid may increase the arrhythmogenic activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Fluvoxamine. The serum concentration of Ivabradine can be decreased when it is combined with Tocilizumab. The serum concentration of Ivabradine can be decreased when it is combined with Siltuximab. Ivabradine may increase the QTc-prolonging activities of Chlorpromazine. The serum concentration of Ivabradine can be increased when it is combined with Indinavir. The serum concentration of Ivabradine can be increased when it is combined with Cyclosporine. The serum concentration of Ivabradine can be increased when it is combined with Isradipine. Ivabradine may increase the QTc-prolonging activities of Chloroquine. The therapeutic efficacy of Ivabradine can be decreased when used in combination with Sarilumab. The serum concentration of Ivabradine can be increased when it is combined with Nilotinib. The serum concentration of Ivabradine can be decreased when it is combined with Bosentan. The serum concentration of Ivabradine can be increased when it is combined with Ketoconazole. Ivabradine may increase the QTc-prolonging activities of Clarithromycin. Bisoprolol may increase the bradycardic activities of Ivabradine. The serum concentration of Ivabradine can be increased when it is combined with Conivaptan. Hydrochlorothiazide may increase the arrhythmogenic activities of Ivabradine. Ivabradine may increase the QTc-prolonging activities of Sulfisoxazole.